News Articles
Browse our entire archive of news articles, spotlight interviews, and other editorial pieces in one place.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Filters
Clearmind Medicine to Pioneer Psychedelic Clinical Trials for Alcohol Use Disorder with Ivy League Universities
Clearmind Medicine
Cybin Announces Grant of Two New United States Patents Protecting its Deuterated DMT Program
Cybin Inc.
Optimi Health Granted Amendment to Dealer's Licence by Health Canada to Supply Special Access Program
Optimi Health
Awakn Life Sciences Submits Clinical Trial Application for Phase III Trial of AWKN-P001
Awakn Life Sciences
Clearmind Medicine Announces Clinical Research Collaboration with Johns Hopkins University to Evaluate CMND-100 in Patients with Alcohol Use Disorder
Clearmind Medicine
Otsuka Pharmaceutical to Acquire Mindset Pharma
Mindset Pharma
Nova Mentis Announces Participant Screening Underway in Canada's First Psilocybin Clinical Trial for Fragile X Syndrome
Nova Mentis Life Science
Cybin to Acquire Small Pharma Inc.
Cybin Inc.
COMPASS Pathways Announces Up to $285 Million Private Placement Financing Joined by Leading Healthcare Investors
Compass Pathways
Algernon NeuroScience Announces 40 Patient Phase 2 Psychedelic Drug DMT Stroke Study
Algernon Pharmaceuticals
Get the Headlines & Market Updates
Be the first to see new company features, exclusive interviews and breaking news. Subscribe now.